Post-operative radioactive iodine administration in patients with low-risk thyroid cancer
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Radioactive iodine (RAI) treatment is used in patients with thyroid cancer to treat disease and to eradicate normal thyroid remnants. Routine post-operative administration of RAI is no longer indicated in patients with low risk thyroid cancer and might instead be used selectively in patients with a post-operative high serum level of thyroglobulin.
Alternative Titles
Full title
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2679234860
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2679234860
Other Identifiers
ISSN
1759-5029
E-ISSN
1759-5037
DOI
10.1038/s41574-022-00709-z
